amrinone has been researched along with Thyrotoxicosis in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An esmolol infusion was started to control his persistent tachycardia but this depressed his myocardial contractility." | 1.29 | Thyrotoxicosis factitia in a post-aortocoronary bypass patient. ( Karski, JM; Redahan, C, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Redahan, C | 1 |
| Karski, JM | 1 |
1 other study available for amrinone and Thyrotoxicosis
| Article | Year |
|---|---|
Thyrotoxicosis factitia in a post-aortocoronary bypass patient.
Topics: Adrenergic beta-Antagonists; Amrinone; Angina, Unstable; Coronary Artery Bypass; Humans; Isoquinolin | 1994 |